The project comes as scorpion stings affect 1.2 million people annually and cause over 3,000 deaths per year, while available antivenoms remain scarce or expensive. Citrini Research reported a compute cost of $49,997 for the 64 hour design phase. While binding to targets is no longer seen as the primary bottleneck in biotech design, researchers estimate that moving from this initial laboratory validation to a released treatment takes between 4 and 7 years.
